By Owen Tucker-Smith
Tempus AI shares sank Monday after the company forecast fourth-quarter sales below Wall Street expectations.
Shares of the Chicago-based artificial intelligence company were recently down 11.7% to $33.14. The stock peaked at $79.49 in June shortly after its initial public offering and hit a low of $22.89 in November.
In preliminary results released Monday, the company said it expected revenue for the fourth quarter around $200 million, an increase of around 35% year-over-year. Analysts on Wall Street surveyed by FactSet expected revenue of $205.7 million.
Chief Executive Eric Lefkofsky said that genomics revenue is expected to grow 30% in the fourth quarter, while data and services revenue is expected to be up 45%.
Tempus is an AI company focused on medicine and healthcare. The company on Monday also said it was developing its first whole-genome sequencing test.
Write to Owen Tucker-Smith at owen.tucker-smith@wsj.com
(END) Dow Jones Newswires
January 13, 2025 10:17 ET (15:17 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。